Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$0.39 - $0.63 $1,989 - $3,213
-5,100 Reduced 14.74%
29,499 $17,000
Q1 2024

May 13, 2024

SELL
$0.28 - $0.9 $1,176 - $3,780
-4,200 Reduced 10.83%
34,599 $28,000
Q4 2023

Feb 13, 2024

SELL
$0.44 - $0.96 $2,114 - $4,612
-4,805 Reduced 11.02%
38,799 $19,000
Q3 2023

Nov 14, 2023

SELL
$0.41 - $1.4 $940 - $3,213
-2,295 Reduced 5.0%
43,604 $27,000
Q2 2023

Aug 11, 2023

SELL
$1.01 - $1.44 $303 - $432
-300 Reduced 0.65%
45,899 $64,000
Q1 2023

May 12, 2023

SELL
$1.18 - $2.59 $1,534 - $3,367
-1,300 Reduced 2.74%
46,199 $55,000
Q4 2022

Feb 13, 2023

SELL
$1.18 - $2.24 $4,130 - $7,840
-3,500 Reduced 6.86%
47,499 $93,000
Q3 2022

Nov 14, 2022

SELL
$1.38 - $2.38 $7,313 - $12,614
-5,300 Reduced 9.41%
50,999 $72,000
Q2 2022

Aug 12, 2022

SELL
$1.8 - $3.74 $2,520 - $5,236
-1,400 Reduced 2.43%
56,299 $136,000
Q1 2022

May 13, 2022

SELL
$2.31 - $3.72 $13,860 - $22,320
-6,000 Reduced 9.42%
57,699 $200,000
Q4 2021

Feb 11, 2022

SELL
$2.61 - $4.9 $33,930 - $63,700
-13,000 Reduced 16.95%
63,699 $183,000
Q3 2021

Nov 12, 2021

SELL
$4.6 - $5.44 $169,740 - $200,736
-36,900 Reduced 32.48%
76,699 $380,000
Q2 2021

Aug 13, 2021

SELL
$4.19 - $5.88 $663,482 - $931,092
-158,349 Reduced 58.23%
113,599 $576,000
Q1 2021

May 13, 2021

SELL
$4.77 - $8.08 $40,311 - $68,284
-8,451 Reduced 3.01%
271,948 $1.56 Million
Q4 2020

Feb 10, 2021

BUY
$4.4 - $5.63 $186,560 - $238,712
42,400 Added 17.82%
280,399 $1.26 Million
Q3 2020

Nov 13, 2020

BUY
$4.75 - $5.99 $434,150 - $547,486
91,400 Added 62.35%
237,999 $1.2 Million
Q2 2020

Aug 13, 2020

BUY
$3.6 - $7.84 $393,480 - $856,912
109,300 Added 293.04%
146,599 $891,000
Q1 2020

May 14, 2020

BUY
$2.76 - $5.44 $63,755 - $125,664
23,100 Added 162.69%
37,299 $142,000
Q4 2019

Feb 13, 2020

BUY
$2.6 - $4.66 $36,917 - $66,167
14,199 New
14,199 $66,000

Others Institutions Holding ORGS

About Orgenesis Inc.


  • Ticker ORGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,545,800
  • Market Cap $28.1M
  • Description
  • Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...
More about ORGS
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.